Cecile Voisset
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Cellular Functional Analyses of ARX Variants Reveal New Insights Into Genotype-Phenotype Correlations in Neurodevelopmental Disorders Among Male and Female Patients.
Journal: Human mutation
Published: July 17, 2025
Anti-prion drugs reduce endoplasmic reticulum stress and protect human dopaminergic neurons from death.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 14, 2025
Bypassing Mendel's First Law: Transmission Ratio Distortion in Mammals.
Journal: International journal of molecular sciences
Published: November 29, 2022
New insights into the regulation of Cystathionine beta synthase (CBS), an enzyme involved in intellectual deficiency in Down syndrome.
Journal: Frontiers in neuroscience
Published: November 28, 2022
Identification of 8-Hydroxyquinoline Derivatives That Decrease Cystathionine Beta Synthase (CBS) Activity.
Journal: International journal of molecular sciences
Published: May 16, 2022
A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families.
Journal: Journal of inherited metabolic disease
Published: March 17, 2022
Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 13, 2020
Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
Journal: European journal of medicinal chemistry
Published: February 21, 2019
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Journal: Human molecular genetics
Published: November 05, 2018
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness.
Journal: Microbial cell (Graz, Austria)
Published: September 16, 2017
Last Updated: 09/26/2026